• G00109
• G10351

• 2.4.1.62
• 2.4.1.92
• 2.4.3.8
• 2.4.3.9
• 3.2.1.18
• 3.2.1.23
• 3.2.1.52

• 15546874

RES
1b:b-dglc-HEX-1:5
2b:b-dgal-HEX-1:5
3b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
4s:n-acetyl
5b:b-dgal-HEX-1:5
6s:n-acetyl
LIN
1:1o(4+1)2d
2:2o(3+2)3d
3:3d(5+1)4n
4:2o(4+1)5d
5:5d(2+1)6n

• Hiraiwa N et al. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies. Cancer Res. 1990 Sep 1;50:(17):5497-503. PMID: 2167157.

• Kotani M et al. Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides. Biochim Biophys Acta. 1992 Jul 21;1117:(1):97-103. doi: 10.1016/0304-4165(92)90168-t. PMID: 1627599.

• Kawashima I et al. Immunocytochemical analysis of gangliosides in rat primary cerebellar cultures using specific monoclonal antibodies. Brain Res. 1996 Sep 2;732:(1-2):75-86. doi: 10.1016/0006-8993(96)00493-3. PMID: 8891271.

• Abregú AV et al. Immunohistochemical detection of hepatic GM1 and GM2 gangliosides in streptozotocin-induced diabetic rats. Hepatol Res. 2002 Nov;24:(3):256. doi: 10.1016/s1386-6346(02)00094-3. PMID: 12393027.

• Tai T et al. Ganglioside GM2 as a human tumor antigen (OFA-I-1). Proc Natl Acad Sci U S A. 1983 Sep;80:(17):5392-6. doi: 10.1073/pnas.80.17.5392. PMID: 6193515.

• Zenita K et al. Northern hybridization analysis of VH gene expression in murine monoclonal antibodies directed to cancer-associated ganglioside antigens having various sialic acid linkages. J Immunol. 1990 Jun 1;144:(11):4442-51. PMID: 2111348.

• Yoshida S et al. Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis. Cancer Res. 2001 May 15;61:(10):4244-52. PMID: 11358851.

• Miyake M et al. The abnormal occurrence and the differentiation-dependent distribution of N-acetyl and N-glycolyl species of the ganglioside GM2 in human germ cell tumors. A study with specific monoclonal antibodies. Cancer. 1990 Feb 1;65:(3):499-505. doi: 10.1002/1097-0142(19900201)65:3<499::aid-cncr2820650321>3.0.co;2-p. PMID: 2153431.

• Shitara K et al. Immunoglobulin class switch of anti-ganglioside monoclonal antibody from IgM to IgG. J Immunol Methods. 1994 Feb 28;169:(1):83-92. doi: 10.1016/0022-1759(94)90127-9. PMID: 8133075.

• Ravindranath MH et al. Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer. Biochem Biophys Res Commun. 2004 Nov 5;324:(1):154-65. doi: 10.1016/j.bbrc.2004.09.029. PMID: 15464996.

• Fredman P et al. A new ganglioside of the lactotetraose series, GalNAc-3'-isoLM1, detected in human meconium. J Biol Chem. 1989 Jul 25;264:(21):12122-5. PMID: 2473071.

• Horikawa K et al. Concanavalin A-stimulated expression of gangliosides with GalNAc beta 1-4(NeuAc alpha 2-3)Gal beta structure in murine thymocytes. Glycoconj J. 1991 Aug;8:(4):354-60. doi: 10.1007/BF00731348. PMID: 1726779.

• Miyake M et al. Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides. Cancer Res. 1988 Nov 1;48:(21):6154-60. PMID: 3167861.

• Duvar S et al. Glycosphingolipid composition of a new immortalized human cerebromicrovascular endothelial cell line. J Neurochem. 2000 Nov;75:(5):1970-6. doi: 10.1046/j.1471-4159.2000.0751970.x. PMID: 11032886.

• Bjerkvig R et al. Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line. Cancer Res. 1991 Sep 1;51:(17):4643-8. PMID: 1873810.

• Natoli EJ Jr et al. A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity. Cancer Res. 1986 Aug;46:(8):4116-20. PMID: 3731079.

• Hedberg KM et al. The glioma-associated gangliosides 3'-isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains. Neuropathol Appl Neurobiol. 2001 Dec;27:(6):451-64. doi: 10.1046/j.1365-2990.2001.00353.x. PMID: 11903928.

• Kawashima I et al. Characterization of ganglioside expression in human melanoma cells: immunological and biochemical analysis. J Biochem. 1993 Aug;114:(2):186-93. doi: 10.1093/oxfordjournals.jbchem.a124153. PMID: 8262898.

• Retter MW et al. Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts. Cancer Res. 2005 Jul 15;65:(14):6425-34. doi: 10.1158/0008-5472.CAN-05-0300. PMID: 16024647.

• Yamaguchi H et al. Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient. Proc Natl Acad Sci U S A. 1990 May;87:(9):3333-7. doi: 10.1073/pnas.87.9.3333. PMID: 2159145.

• Sorice M et al. Evidence for the existence of ganglioside molecules in the antigen of Entamoeba histolytica. Parasite Immunol. 1996 Mar;18:(3):133-7. doi: 10.1046/j.1365-3024.1996.d01-67.x. PMID: 9223167.

• Karlsson G et al. Characterization of the binding epitope of the monoclonal antibody DMAb-1 to ganglioside GM2. Biochim Biophys Acta. 1990 Apr 17;1043:(3):267-72. doi: 10.1016/0005-2760(90)90026-t. PMID: 1691018.

• Vrionis FD et al. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines. Cancer Res. 1989 Dec 1;49:(23):6645-51. PMID: 2479468.

• Vick WW et al. Application of a panel of antiganglioside monoclonal antibodies to cytologic specimens. Acta Cytol. 1992 Sep-Oct;36:(5):697-705. PMID: 1523927.

• Kotani M et al. Immunohistochemical localization of minor gangliosides in the rat central nervous system. Glycobiology. 1994 Dec;4:(6):855-65. doi: 10.1093/glycob/4.6.855. PMID: 7734848.

• Dohi T et al. Sialylpentaosylceramide detected with anti-GM2 monoclonal antibody. Structural characterization and complementary expression with GM2 in gastric cancer and normal gastric mucosa. J Biol Chem. 1990 May 15;265:(14):7880-5. PMID: 2139874.